Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

177 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Medullary thyroid cancer treated by capecitabine.
Labidi SI, Gravis G, Tarpin C, Brun V, Viens P. Labidi SI, et al. Anticancer Drugs. 2007 Aug;18(7):831-4. doi: 10.1097/CAD.0b013e3280adc8f3. Anticancer Drugs. 2007. PMID: 17581307
[Contamination of cytapheresis by tumor cells: apropos of 39 breast cancer cases].
Mozziconacci MJ, Arnoulet C, Novakovitch G, Chabannon C, Viens P, Gravis G, Faucher C, Blaise D, Maraninchi D, Sainty D. Mozziconacci MJ, et al. Bull Cancer. 1996 Aug;83(8):649-53. Bull Cancer. 1996. PMID: 8869045 French.
The purpose of the present study was the detection of tumor cells in aphereses after mobilization of peripheral blood stem cells (PBSCs) with G-CSF from 39 breast cancer patients. ...In our study, presence of tumor cells was associated with advanced clinical stage and coul …
The purpose of the present study was the detection of tumor cells in aphereses after mobilization of peripheral blood stem cells (PBSCs) wit …
Impact of recombinant human granulocyte colony stimulating factor on dose intensity and toxicity of three cycles of methotrexate, vinblastine, doxorubicin and cisplatin in patients with previously untreated urothelial bladder carcinoma.
Viens P, Gravis G, Bladou F, Lechevallier E, Baume D, Camerlo J, Cowen D, Coulange C, Serment G, Resbeut M, Maraninchi D. Viens P, et al. Eur Cytokine Netw. 1996 Sep;7(3):395-9. Eur Cytokine Netw. 1996. PMID: 8954183 Clinical Trial.
High-dose sequential chemotherapy with stem cell support for non-metastatic breast cancer.
Viens P, Gravis G, Genre D, Bertucci F, Cowen D, Camerlo J, Cappiello MA, Conte M, Finaud M, Chabannon C, Houvenaeghel G, Maraninchi D. Viens P, et al. Bone Marrow Transplant. 1997 Aug;20(3):199-203. doi: 10.1038/sj.bmt.1700870. Bone Marrow Transplant. 1997. PMID: 9257887
The aim of this study was to evaluate the feasibility of a high-dose intensity doxorubicin-cyclophosphamide regimen with supporting G-CSF and blood stem cells. ...G-CSF was started on day 3 of each cycle (5 microg/kg/day) and was stopped the day before the last aphe …
The aim of this study was to evaluate the feasibility of a high-dose intensity doxorubicin-cyclophosphamide regimen with supporting G
[Intensive chemotherapy with autologous stem cell transplantation in ovarian cancers: analysis of 67 patients treated at the Paoli-Calmettes Institute and a review of the literature].
Viens P, Bertucci F, Gravis G, Camerlo J, Cowen D, Delpero JR, Conte M, Jacquemier J, Faucher C, Blaise D, Bardou VJ, Chabannon C, Blanc AP, Jaubert D, Maraninchi D. Viens P, et al. Bull Cancer. 1997 Sep;84(9):869-76. Bull Cancer. 1997. PMID: 9435808 Review. French.
High-dose chemotherapy and haematopoietic stem cell transplantation for inflammatory breast cancer: pathologic response and outcome.
Viens P, Penault-Llorca F, Jacquemier J, Gravis G, Cowen D, Bertucci F, Houvenaeghel G, Blaise D, Maraninchi D. Viens P, et al. Bone Marrow Transplant. 1998 Feb;21(3):249-54. doi: 10.1038/sj.bmt.1701074. Bone Marrow Transplant. 1998. PMID: 9489647 Clinical Trial.
Benefits of granulocyte-colony-stimulating factor after stem cell transfusion in intensive sequential chemotherapy for breast cancer.
Viens P, Genre D, Protière C, Gravis G, Bertucci F, Cowen D, Camerlo J, Chabannon C, Novakovitch G, Conte M, Finaud M, Moatti JP, Maraninchi D. Viens P, et al. Eur Cytokine Netw. 1998 Mar;9(1):93-8. Eur Cytokine Netw. 1998. PMID: 9613683 Clinical Trial.
Women with poor-prognosis breast cancer received four cycles of high-dose cyclophosphamide (3 g/m2) and doxorubicin (75 mg/m2), followed by filgrastim 5 microg/kg/dy, stem cell collection after the cycle 1, and stem cell infusion after cycle 3 and cycle 4. ...
Women with poor-prognosis breast cancer received four cycles of high-dose cyclophosphamide (3 g/m2) and doxorubicin (75 mg/m2), follo …
High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study.
Chabannon C, Cornetta K, Lotz JP, Rosenfeld C, Shlomchik M, Yanovitch S, Marolleau JP, Sledge G, Novakovitch G, Srour EF, Burtness B, Camerlo J, Gravis G, Lee-Fischer J, Faucher C, Chabbert I, Krause D, Maraninchi D, Mills B, Kunkel L, Oldham F, Blaise D, Viens P. Chabannon C, et al. Br J Cancer. 1998 Oct;78(7):913-21. doi: 10.1038/bjc.1998.601. Br J Cancer. 1998. PMID: 9764583 Free PMC article. Clinical Trial.
rIL-2 in metastatic soft tissue sarcomas refractory to chemotherapy: response and enhancement of further chemosensitivity.
Gravis G, Viens P, Delva R, Baume D, Blaise D, Ternier F, Houvenaeghel G, Brandely M, Resbeut M, Maraninchi D. Gravis G, et al. Anticancer Res. 1998 Sep-Oct;18(5B):3699-704. Anticancer Res. 1998. PMID: 9854480 Clinical Trial.
Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma: side effects, quality of life, and organization.
Macquart-Moulin G, Viens P, Genre D, Bouscary ML, Resbeut M, Gravis G, Camerlo J, Maraninchi D, Moatti JP. Macquart-Moulin G, et al. Cancer. 1999 May 15;85(10):2190-9. Cancer. 1999. PMID: 10326697 Clinical Trial.
177 results
Jump to page
Feedback